Aram Lyu

[Parker Institute for Cancer Immunotherapy @parkerici]

Meet 2023 Parker Scholar Aram Lyu, PhD @aramlyu @UCSFMedicine. He is using myeloid cells to mediate immunotherapy resistance in prostate cancer that has metastasized. Hear his thoughts on the future of #cancerresearch here: https://t.co/1BbKlzPhip

#PICINetwork

[Parker Institute for Cancer Immunotherapy @parkerici]

Today we announced our 2023 class of Early Career Researcher awardees – 8 exceptional graduate and postdoctoral researchers from leading academic institutions who will share up to $2.9 million for their innovative research #PICINetwork

Meet them here: https://t.co/Qdlls1BxFd

[Prostate Cancer Foundation @PCFnews]

Celebrating the next generation of researchers at the @AACR Annual Meeting! @AndreaMiyahira joined the 2026 recipients of the PCF Scholar-in-Training Awards, recognizing outstanding early-career scientists presenting impactful work in prostate cancer. #AACR26

[Society for Immunotherapy of Cancer @sitcancer]

Welcome to the 2026 #SITC #Sparkathon participants (Sparkies). We would like to thank them for participating in this unique program to advance their careers in immuno-oncology! #TCells #IO #SITCQuestfor100

[Prostate Cancer Foundation @PCFnews]

The 2024 Young Investigator Awards recipients have just been announced. Congrats to this year’s class, who received $6.3 million in funding for innovative prostate cancer research.

Meet this year’s class: https://t.co/9ZJR85TxCg

#ProstateCancer #MedEd #MedX

[JCI insight @JCI_insight]

ASCI member Fong et al. @UCSF show that JAK inhibition administered sequentially enhances anti-tumor immunity after combined anti-PD-1 and anti-CTLA4 therapy in pre-clinical prostate cancer study: https://t.co/H1fKT3E8cI

[Marcel Arias @MarcelArias]

Think global, act local! Just like the fully cleavable, conditionally activatable DVD CTLA4 blockade we report at https://t.co/WYYJAWXGP0 ! It provided safe, primary antigen-specific antitumor efficacy in localized and systemic preclinical tumor models. @lawfong

[Marcel Arias @MarcelArias]

In this fantastic collaboration with Abbvie we were able to find time-sensitive synergistic effects between immune checkpoint blockade and JAK1 inhibition in boosting T cell fitness against tumors in mice. Online today! https://t.co/T0EbhEuAtw @lawfong

[AACR @AACR]

Aram Lyu, Peiqi Ou, Helen Rizos, and Annette Paschen discuss "Cancer Immune Evasion" in a symposium at the AACR IO Conference on Discovery and Innovation in Cancer Immunology. #AACRIO25 @HelenRizos @AramLyu

[Journal of Clinical Investigation @jclinicalinvest]

How do prostate tumor cells dodge the immune system? https://t.co/RHrYzRQYBD

@Ru_M_Wen & team reveal an interaction between sialic acid-modified proteins on tumor cells and Siglec7/9 on immune cells and identify CD59 as a candidate for targeting!

@JessicaCStark @riley_nm1 @Xiangyue_CA @AramLyu @lawfong @CarolynBertozzi @StanfordUrology @StanfordCancer

[nature @Nature]

Nature research paper: Evolution of myeloid-mediated immunotherapy resistance in prostate cancer https://t.co/fp7QFBMpNr

[ACIR @ACIR_org]

ScRNAseq of prostate cancer samples revealed an SPP1hi TAM population that correlated with progression and T cell exhaustion. https://t.co/KV2qtGWDIE  @AramLyu  @parkerici  @lawfong

[Fred Hutch Cancer Center @fredhutch]

Fred Hutch researchers shared new research at the @sitcancer meeting in early Nov. Findings included new strategies to avoid T-cell exhaustion in CAR T cells & insights into how solid tumors change microenvironment to blunt the immune system’s response.
https://t.co/GNf8WOzd05

[Parker Institute for Cancer Immunotherapy @parkerici]

Why has immunotherapy, transformative for some cancers, struggled in prostate cancer? A new @Nature study, led by @lawfong (former PICI Co-Director at @UCSF, now at @fredhutch) with 1st author Aram Lyu, PhD (PICI Investigator, UCSF), uncovers key insights. 1/3

[Lawrence Fong MD @lawfong]

We are happy to share our work led by @AramLyu and Zenghua Fan on why prostate cancer is so resistant to immunotherapy.
https://t.co/QIujWAbUTy